Intervexion Therapeutics, LLC

Little Rock, AR 72205

SBIR Award Summary

Total Number of Awards 7
Total Value of Awards $3.15MM
First Award Date 09/10/04
Most Recent Award Date 07/01/08

Key Personnel

Last Name Name Awards Contact
Holtz R. Barry Holtz 7

7 Awards Won

Phase 2 STTR

Agency: Department of Health & Human Services
Topic: RFA-DA-03-015
Budget: 07/01/08 - 06/30/11

DESCRIPTION (provided by applicant): The goal of this combination Phase I / Phase II STTR project is to test the hypothesis that anti-drug monoclonal antibodies are a safe and effective therapy for the medical problems associated with phencyclidine (PCP) abuse. There are currently no specific medications for treating the medical problems cau...

Phase 2 STTR

Agency: Department of Health & Human Services
Topic: RFA-DA-03-015
Budget: 07/01/08 - 06/30/11

DESCRIPTION (provided by applicant): The goal of this combination Phase I / Phase II STTR project is to test the hypothesis that anti-drug monoclonal antibodies are a safe and effective therapy for the medical problems associated with phencyclidine (PCP) abuse. There are currently no specific medications for treating the medical problems cau...

Phase 2 STTR

Agency: Department of Health & Human Services
Topic: RFA-DA-03-15
Budget: 07/01/08 - 06/30/10

DESCRIPTION (provided by applicant): The goal of this combination Phase I / Phase II STTR project is to test the hypothesis that anti-drug monoclonal antibodies are a safe and effective therapy for the medical problems associated with phencyclidine (PCP) abuse. There are currently no specific medications for treating the medical problems cau...

Phase 2 STTR

Agency: Department of Health & Human Services
Topic: RFA-DA-03-15
Budget: 07/01/07 - 06/30/08

DESCRIPTION (provided by applicant): The goal of this combination Phase I / Phase II STTR project is to test the hypothesis that anti-drug monoclonal antibodies are a safe and effective therapy for the medical problems associated with phencyclidine (PCP) abuse. There are currently no specific medications for treating the medical problems cau...

Phase 2 STTR

Agency: Department of Health & Human Services
Topic: RFA-DA-03-15
Budget: 07/01/06 - 06/30/07

DESCRIPTION (provided by applicant): The goal of this combination Phase I / Phase II STTR project is to test the hypothesis that anti-drug monoclonal antibodies are a safe and effective therapy for the medical problems associated with phencyclidine (PCP) abuse. There are currently no specific medications for treating the medical problems cau...

Phase 2 STTR

Agency: Department of Health & Human Services
Topic: RFA-DA-03-15
Budget: 07/01/05 - 06/30/06

DESCRIPTION (provided by applicant): The goal of this combination Phase I / Phase II STTR project is to test the hypothesis that anti-drug monoclonal antibodies are a safe and effective therapy for the medical problems associated with phencyclidine (PCP) abuse. There are currently no specific medications for treating the medical problems cau...

Phase 2 STTR

Agency: Department of Health & Human Services
Topic: RFA-DA-03-15
Budget: 09/10/04 - 06/30/05

DESCRIPTION (provided by applicant): The goal of this combination Phase I / Phase II STTR project is to test the hypothesis that anti-drug monoclonal antibodies are a safe and effective therapy for the medical problems associated with phencyclidine (PCP) abuse. There are currently no specific medications for treating the medical problems cau...